Business
Curaleaf Celebrates President Trump's Landmark Rescheduling of Cannabis Under Controlled Substances Act
Curaleaf Celebrates President Trump's Landmark Rescheduling of Cannabis Under Controlled Substanc...
About this update from Curaleaf Holdings, Inc.
[{"type":"text","content":"Curaleaf Celebrates President Trump's Landmark Rescheduling of Cannabis Under Controlled Substances Act\n\n\nCuraleaf Celebrates President Trump's Landmark Rescheduling of Cannabis Under Controlled Substances Act\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\nPR Newswire\n\n\nTrump Administration's Rescheduling Opens New Avenues for Research, Medical Advancement, and Investment\nSTAMFORD, Conn., Dec. 18, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (\"Curaleaf\" or the \"Company\"), a leading international provider of consumer cannabis products, today applauds the Trump Administration's action to implement the most impactful federal cannabis reform of the past fifty years by rescheduling cannabis as a Schedule III substance under the Controlled Substances Act of 1970.\n\n\n\n\n\n\n\n\"Curaleaf thanks President Trump for acting on his commitment to move forward with cannabis reclassification and we express our deep gratitude to him for this bold move,\" said Boris Jordan, Chairman and CEO of Curaleaf. \"Moving the plant from Schedule I to Schedule III acknowledges what has been known for thousands of years, that the cannabis plant has medicinal properties. This policy shift by the United States government sets a precedent for how cannabis should be viewed globally and we eagerly await Attorney General Pam Bondi's prompt execution of President Trump's order.\"\nRescheduling cannabis to Schedule III is a meaningful step toward destigmatizing the plant by opening avenues to federally funded clinical research, supporting veterans, expanding patient access, and more. It also eliminates onerous tax penalties and creates opportunities for expanded investment into state programs that will create jobs and tax revenue for local communities.\n\"Under President Trump's leadership,\" Jordan continued, \"this historic action will help bring logic to federal cannabis policy, ensuring the law reflects both scientific understanding and widespread public support. Momentum has been building across party lines for decades, and n...